BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 32309045)

  • 21. A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma.
    Guo Y; Wang Z; Tian Y; Li L; Dong J
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
    Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
    World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma.
    Zhang J; Wu Y; Mu J; Xin D; Wang L; Fan Y; Zhang S; Xu Y
    Front Oncol; 2022; 12():954226. PubMed ID: 36203430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
    Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer.
    Chen S; Li X; Guo L; Zhang J; Li L; Wang X; Zhu Y; Wang J
    J BUON; 2021; 26(5):1931-1941. PubMed ID: 34761602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 27. A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.
    Zhong L; Zhu J; Shu Q; Xu G; He C; Fang L
    J Oncol; 2023; 2023():5925935. PubMed ID: 36844874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.
    Zhou C; Wang S; Zhou Q; Zhao J; Xia X; Chen W; Zheng Y; Xue M; Yang F; Fu D; Yin Y; Atyah M; Qin L; Zhao Y; Bruns C; Jia H; Ren N; Dong Q
    Front Oncol; 2019; 9():1160. PubMed ID: 31781487
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovered differentially expressed lncRNA AC010973.2 can act as a diagnostic and prognostic biomarker for colon adenocarcinoma.
    Liu X; Xiao C; Tan F; Yi R; Zhao X
    Transl Cancer Res; 2020 Oct; 9(10):6275-6286. PubMed ID: 35117237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A seven-lncRNA signature for predicting prognosis in breast carcinoma.
    Xu M; Chen Z; Lin B; Zhang S; Qu J
    Transl Cancer Res; 2021 Sep; 10(9):4033-4046. PubMed ID: 35116701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
    Zhou W; Zhang S; Li HB; Cai Z; Tang S; Chen LX; Lang JY; Chen Z; Chen XL
    Biomed Res Int; 2020; 2020():9807918. PubMed ID: 32964050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.
    Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K
    Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A four-lncRNA risk signature for prognostic prediction of osteosarcoma.
    Liu H; Chen C; Liu L; Wang Z
    Front Genet; 2022; 13():1081478. PubMed ID: 36685868
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.